Latin America Breast Biopsy Needle Market – Industry Trends and Forecast to 2031

라틴 아메리카 유방 생검 바늘 시장 분석 및 규모

유방 생검 바늘 시장은 미세 바늘 흡인 생검, 코어 바늘 생검, 진공 보조 생검, 영상 유도 생검을 포함한 다양한 생검 기술을 포괄합니다. 미세 바늘 흡인 생검은 세포학 평가를 위해 세포를 추출하는 것을 포함합니다. 코어 바늘 생검은 조직학적 검사를 위해 조직 샘플을 회수합니다. 진공 보조 생검은 향상된 조직 회수를 위해 흡입을 사용하는 반면, 영상 유도 생검은 정확한 조직 타겟팅을 위해 영상 모달리티를 활용하여 유방 이상을 정확하게 진단하는 데 도움이 됩니다.

Data Bridge Market Research는 2023년에 2,225만 달러였던 라틴 아메리카 유방 생검 바늘 시장이 2031년까지 4,028만 달러에 도달할 것으로 분석했으며, 2024년부터 2031년까지의 예측 기간 동안 연평균 성장률은 7.7%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화      

시장 정의

유방 생검 바늘은 진단 평가를 위해 유방에서 조직 샘플을 추출하는 데 사용되는 의료 기구입니다. 일반적으로 절삭 날 또는 진공 메커니즘이 있는 속이 빈 가느다란 튜브로 구성되어 있어 분석을 위해 조직을 정확하게 타겟팅하고 회수할 수 있어 유방 이상을 탐지하고 진단하는 데 도움이 됩니다.

라틴 아메리카 유방 생검 바늘 시장 동향

운전자

• 생검 바늘 효능을 강화하는 기술 혁신

기술적 발전에는 더 날카롭고 정확한 바늘과 초음파 및 MRI 유도 생검과 같은 영상 기술의 개발이 포함되어 진단 정확도와 환자 편안함을 향상시킵니다. 향상된 샘플링 품질을 제공하고 시술 시간을 줄임으로써 이러한 혁신은 최소 침습적 생검 시술에 대한 증가하는 수요에 부응합니다. 결과적으로 유방 생검 바늘 시장은 주로 생검 바늘 효능과 환자 결과를 향상시키는 것을 목표로 하는 기술의 지속적인 발전에 의해 주도됩니다.

• 고령화 인구가 생검율 상승에 기여

개인이 나이가 들면서 유방 이상과 암의 발생률이 증가하여 생검과 같은 더 빈번한 진단 절차가 필요합니다. 이러한 인구학적 추세는 유방 생검 바늘에 대한 수요가 더 커짐으로 이어집니다. 결과적으로 제조업체는 이러한 증가하는 수요를 충족하기 위해 고급 생검 장치를 개발하여 대응하고 있습니다. 따라서 고령화 인구가 생검율에 미치는 영향은 유방 생검 바늘 시장을 형성하는 주요 동인으로 부상합니다.

기회

• 전 세계적으로 유방암 발병률 증가

유방암 발병률이 증가함에 따라 조기 발견 및 치료를 용이하게 하는 정확한 진단 도구에 대한 수요가 증가하고 있습니다. 유방 생검 바늘은 조직학적 검사를 위한 조직 샘플을 얻는 데 중요한 역할을 하며, 정확한 진단 및 치료 계획에 도움이 됩니다. 생검 바늘에 대한 이러한 수요 증가는 유방암 진단 및 관리에 대한 시장 성장 및 혁신의 기회를 강조합니다.

• 생체검사 안내를 위한 인공지능 통합

AI-driven systems can enhance biopsy accuracy by providing real-time guidance, improving targeting precision, and reducing procedural errors. By leveraging AI algorithms for image analysis and biopsy planning, healthcare providers can streamline biopsy procedures, leading to quicker diagnoses and improved patient outcomes. This integration not only enhances biopsy efficiency but also opens avenues for innovative AI-driven solutions, shaping the future of breast cancer diagnosis.

Restraints/Challenges

• Lack of Skilled Healthcare Professionals Performing Biopsies

The lack of skilled healthcare professionals reduces the frequency and quality of biopsies conducted, delaying or preventing timely detection and treatment of breast abnormalities. Additionally, the shortage of skilled personnel may lead to increased wait times for biopsy appointments, causing anxiety and frustration for patients. Consequently, the market faces challenges in expanding its reach and achieving optimal utilization of biopsy technologies in breast cancer diagnosis and management.

• High Costs Associated with Biopsy Procedures

The elevated expenses may deter individuals from undergoing biopsy examinations, leading to delayed diagnoses and treatment interventions. Moreover, healthcare providers may face financial constraints in procuring advanced biopsy needle technologies, hindering technological advancements and innovation within the market.

This Latin America breast biopsy needle market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Latin America breast biopsy needle market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Argon Medical Devices introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument, a new addition to the biopsy needle market. This innovative device aims to improve biopsy procedures with enhanced efficiency and precision, potentially offering healthcare professionals advanced tools to enhance diagnostic accuracy and patient outcomes
• In April 2021, AprioMed extended its collaboration with Cenova, aiming to bolster its foothold in the South American market. This strategic alliance may enhance their presence and offerings in the breast biopsy needle market, potentially enabling AprioMed to capitalize on emerging opportunities and meet the region's healthcare needs more effectively
• In February 2021, Hologic Inc's acquisition of biotheranostics marked their entry into the expanding oncology market, including breast cancer. This strategic move enhances their network and capabilities in cancer diagnostics, potentially benefiting their offerings in the breast biopsy needle market through increased innovation and market presence

Latin America Breast Biopsy Needle Market Scope

The Latin America breast biopsy needle market is segmented on the basis of needle type, ergonomics, procedure, usability, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Needle Type

• Fine-Needle Aspiration
• Core Needle

Ergonomic

• Sharp
• Blunt
• Quincke
• Chiba
• Franseen
• Others

Procedure

• Fine- Needle Aspiration Biopsy
• Core Needle Biopsy
• Vacuum-Assisted Biopsy
• Image-Guided Biopsy

Usability

• Disposable
• Reusable

 Application

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

End User

• Hospitals
• Diagnostic Centres
• Biopsy Labs
• Ambulatory Surgical Centres
• Academic and Research Organizations
• Others

Distribution Channel

• Direct Tender
• Retail Sales

Latin America Breast Biopsy Needle Market Regional Analysis/Insights

The Latin America breast biopsy needle market is analysed and market size insights and trends are provided by needle type, ergonomics, procedure, usability, application, end user and distribution channel as referenced above.

The countries covered in the Latin America breast biopsy needle market report are U.S., Mexico, Brazil, Argentina, Columbia, Chile, Peru, Uruguay, Bolivia and Rest of Latin America.

Brazil dominates the breast biopsy needle market is fueled by a rising incidence of breast cancer and increased public awareness of cancer screening. This creates a favorable environment for growth, as demand for biopsy needles for diagnostic purposes surges.

Mexico leads the breast biopsy needle market driven by a growing geriatric population, which is more susceptible to breast cancer. As the elderly demographic expands, demand for biopsy needles rises, fueling market dominance in the country.

Argentina's dominance in the breast biopsy needle market stems from the increasing utilization of artificial intelligence and machine learning to enhance diagnostic procedures. This technological integration fosters more accurate and efficient biopsy processes, driving market leadership in Argentina.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The Latin America breast biopsy needle market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Latin America breast biopsy needle market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Latin America breast biopsy needle market. The data is available for historic period 2016-2021.

Competitive Landscape and Latin America Breast Biopsy Needle Market Share Analysis

The Latin America breast biopsy needle market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Latin America breast biopsy needle market.

Some of the major players operating in the Latin America breast biopsy needle market are:

• Medax SRL (Italy)
• Cook (U.S.)
• BD  (U.S.)
• AprioMed AB (Sweden)
• INRAD Inc. (U.S.)
• Hologic, Inc. (U.S.)
• Möller Medical GmbH (Germany)
• IZI Medical Products (U.S.)
• Merit Medical Systems, Inc. (U.S.)
• ADRIA MEDICAL (France)
• Devicor Medical Products Inc. (U.S.)
• Remington Medical Inc. (U.S.)
• PAJUNK GmbH (Germany)

SKU-64258